Jaguar Health Inc (NASDAQ:JAGX) has a beta value of 0.87 and has seen 0.57 million shares traded in the recent trading session. The company, currently valued at $11.20M, closed the recent trade at $0.95 per share which meant it gained $0.03 on the day or 3.65% during that session. The JAGX stock price is -2173.68% off its 52-week high price of $21.60 and 11.58% above the 52-week low of $0.84. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.73 million shares traded. The 3-month trading volume is 353.07K shares.
The consensus among analysts is that Jaguar Health Inc (JAGX) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.74.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Jaguar Health Inc (NASDAQ:JAGX) trade information
Sporting 3.65% in the green today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the JAGX stock price touched $0.95 or saw a rise of 26.36%. Year-to-date, Jaguar Health Inc shares have moved -89.55%, while the 5-day performance has seen it change -4.12%. Over the past 30 days, the shares of Jaguar Health Inc (NASDAQ:JAGX) have changed -1.10%. Short interest in the company has seen 0.33 million shares shorted with days to cover at 1.12.
Jaguar Health Inc (JAGX) estimates and forecasts
Figures show that Jaguar Health Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -75.72% over the past 6 months, with this year growth rate of 99.26%, compared to 16.50% for the industry.
1 analysts offering their estimates for the company have set an average revenue estimate of 3.13M for the current quarter. 1 have an estimated revenue figure of 3.29M for the next ending quarter.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 86.10% over the past 5 years. Earnings growth for 2024 is a modest 99.26% while over the next 5 years, the company’s earnings are expected to increase by 40.00%.
JAGX Dividends
Jaguar Health Inc is expected to release its next earnings report in January this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Jaguar Health Inc (NASDAQ:JAGX)’s Major holders
Insiders own 12.02% of the company shares, while shares held by institutions stand at 1.96% with a share float percentage of 2.22%. Investors are also buoyed by the number of investors in a company, with Jaguar Health Inc having a total of 12.0 institutions that hold shares in the company.
